Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3759)
All Articles published online
|
Nov 15, 2003 (publication date) through Jul 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li X, Feng GS, Zheng CS, Zhuo CK, Liu X. Influence of transarterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor and basic fibroblast growth factor in rat with Walker-256 transplanted hepatoma: An experimental study. World J Gastroenterol 2003; 9(11): 2445-2449 [PMID: 14606073 DOI: 10.3748/wjg.v9.i11.2445] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i11/2445.htm |
| Number | Citing Articles |
| 1 |
Ju Hyun Shim, Joong‐Won Park, Ji Hoon Kim, Min An, Sun‐Young Kong, Byung‐Ho Nam, Joon‐Il Choi, Hyun Beom Kim, Woo Jin Lee, Chang‐Min Kim. Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients. Cancer Science 2008; 99(10): 2037 doi: 10.1111/j.1349-7006.2008.00909.x
|
| 2 |
Daisaku Yamada, Shogo Kobayashi, Hirofumi Yamamoto, Yoshito Tomimaru, Takehiro Noda, Mamoru Uemura, Hiroshi Wada, Shigeru Marubashi, Hidetoshi Eguchi, Masahiro Tanemura, Yuichiro Doki, Masaki Mori, Hiroaki Nagano. Role of the Hypoxia-Related Gene, JMJD1A, in Hepatocellular Carcinoma: Clinical Impact on Recurrence after Hepatic Resection. Annals of Surgical Oncology 2012; 19(S3): 355 doi: 10.1245/s10434-011-1797-x
|
| 3 |
Hai-Lin Li, Wen-Bin Ji, Rui Zhao, Wei-Dong Duan, Yong-Wei Chen, Xian-Qiang Wang, Qiang Yu, Ying Luo, Jia-Hong Dong. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: Retrospective analysis. World Journal of Gastroenterology 2015; 21(12): 3599-3606 doi: 10.3748/wjg.v21.i12.3599
|
| 4 |
Katerina Malagari, Mary Pomoni, Alexis Kelekis, Anastasia Pomoni, Spyros Dourakis, Themis Spyridopoulos, Hippokratis Moschouris, Emmanouil Emmanouil, Spyros Rizos, Dimitrios Kelekis. Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma. CardioVascular and Interventional Radiology 2010; 33(3): 541 doi: 10.1007/s00270-009-9750-0
|
| 5 |
Bingru Xie, David H. Wang, Stuart Jon Spechler. Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review. Digestive Diseases and Sciences 2012; 57(5): 1122 doi: 10.1007/s10620-012-2136-1
|
| 6 |
Paolo Giunchedi, Marcello Maestri, Elisabetta Gavini, Paolo Dionigi, Giovanna Rassu. Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1. Expert Opinion on Drug Delivery 2013; 10(5): 679 doi: 10.1517/17425247.2013.770733
|
| 7 |
C. Damiano Gadaleta, Girolamo Ranieri. Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitors. Critical Reviews in Oncology/Hematology 2011; 80(1): 40 doi: 10.1016/j.critrevonc.2010.10.005
|
| 8 |
Mona El-Azab, Hailemichael Hishe, Yasser Moustafa, El-Sayed El-Awady. Anti-angiogenic effect of resveratrol or curcumin in Ehrlich ascites carcinoma-bearing mice. European Journal of Pharmacology 2011; 652(1-3): 7 doi: 10.1016/j.ejphar.2010.11.008
|
| 9 |
Masatoshi Kudo, Guohong Han, Richard S. Finn, Ronnie T.P. Poon, Jean-Frederic Blanc, Lunan Yan, Jijin Yang, Ligong Lu, Won-Young Tak, Xiaoping Yu, Joon-Hyeok Lee, Shi-Ming Lin, Changping Wu, Tawesak Tanwandee, Guoliang Shao, Ian B. Walters, Christine Dela Cruz, Valerie Poulart, Jian-Hua Wang. Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial. Hepatology 2014; 60(5): 1697 doi: 10.1002/hep.27290
|
| 10 |
David Semela, Jean-François Dufour. Signaling Pathways in Liver Diseases. 2005; : 91 doi: 10.1007/3-540-27194-5_8
|
| 11 |
Elisa Pinto, Filippo Pelizzaro, Romilda Cardin, Michele Battistel, Giorgio Palano, Federica Bertellini, Maria Piera Kitenge, Giulia Peserico, Fabio Farinati, Francesco Paolo Russo. HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization. Digestive and Liver Disease 2024; 56(5): 872 doi: 10.1016/j.dld.2023.09.019
|
| 12 |
Tongqiang Li, Jiacheng Liu, Yingliang Wang, Chen Zhou, Qin Shi, Songjiang Huang, Chongtu Yang, Yang Chen, Yaowei Bai, Bin Xiong. Liver fibrosis promotes immunity escape but limits the size of liver tumor in a rat orthotopic transplantation model. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-02155-9
|
| 13 |
Katerina Malagari, Mary Pomoni, Themistoklis N. Spyridopoulos, Hippokratis Moschouris, Alexis Kelekis, Spyros Dourakis, Efthymia Alexopoulou, John Koskinas, Michalis Angelopoulos, John Kornezos, Anastasia Pomoni, Savvas Tandeles, Athanasios Marinis, Spyros Rizos, Dimitrios Kelekis. Safety Profile of Sequential Transcatheter Chemoembolization with DC Bead™: Results of 237 Hepatocellular Carcinoma (HCC) Patients. CardioVascular and Interventional Radiology 2011; 34(4): 774 doi: 10.1007/s00270-010-0044-3
|
| 14 |
Bianca Rocco, Valentina Camelo, Valeria Feliciangeli, Carlo Catalano, Pierleone Lucatelli. Transarterial Chemoembolization (TACE). 2023; : 1 doi: 10.1007/978-3-031-36261-3_1
|
| 15 |
Hye Ok Kim, Jae Seung Kim, Yong Moon Shin, Jin-Sook Ryu, Yung Sang Lee, Seung Gyu Lee. Evaluation of Metabolic Characteristics and Viability of Lipiodolized Hepatocellular Carcinomas Using18F-FDG PET/CT. Journal of Nuclear Medicine 2010; 51(12): 1849 doi: 10.2967/jnumed.110.079244
|
| 16 |
Jannis Kountouras, Christos Zavos, Dimitrios Chatzopoulos. Apoptotic and anti-angiogenic strategies in liver and gastrointestinal malignancies. Journal of Surgical Oncology 2005; 90(4): 249 doi: 10.1002/jso.20254
|
| 17 |
|
| 18 |
Heng-Yi LIANG, Li-Gong LU, Bao-Shan HU, Yong LI, Pei-Jian SHAO. Effects of sorafenib combined with chemoembolization and radiofrequency ablation for large, unresectable hepatocellular carcinomas. Chinese Medical Journal 2013; 126(22): 4270 doi: 10.3760/cma.j.issn.0366-6999.20120478
|
| 19 |
David J. Pennisi, Takashi Mikawa. Normal patterning of the coronary capillary plexus is dependent on the correct transmural gradient of FGF expression in the myocardium. Developmental Biology 2005; 279(2): 378 doi: 10.1016/j.ydbio.2004.12.028
|
| 20 |
Junning Liu, Shu Yan, Guangnian Zhang, Linfeng Yang, Song Wei, Pengsheng Yi. A retrospective study of transarterial chemoembolization (TACE) combined with lenvatinib compared with TACE monotherapy for BCLC B2 stage hepatocellular carcinoma. Oncology Letters 2023; 26(6) doi: 10.3892/ol.2023.14094
|
| 21 |
David Semela, Jean-François Dufour. Signaling Pathways in Liver Diseases. 2010; : 421 doi: 10.1007/978-3-642-00150-5_28
|
| 22 |
Ko Oshita, Tsuyoshi Kobayashi, Yosuke Namba, Sotaro Fukuhara, Keiso Matsubara, Daisuke Takei, Ryosuke Nakano, Wataru Okamoto, Hiroshi Sakai, Naoki Tanimine, Takashi Nakahara, Shintaro Kuroda, Hiroyuki Tahara, Masahiro Ohira, Tomokazu Kawaoka, Kentaro Ide, Michio Imamura, Hiroshi Aikata, Hideki Ohdan. Efficacy and safety of lenvatinib–transcatheter arterial chemoembolisation sequential therapy followed by surgical resection for intermediate-stage hepatocellular carcinoma beyond Up-to-7 criteria: a study protocol for a multicentre, single-arm, prospective study. BMJ Open 2023; 13(10): e073797 doi: 10.1136/bmjopen-2023-073797
|
| 23 |
Juan Wu, Jia Zeng, Huiwen Wang, Zhuoni Huo, Xunbo Hou, Dongfeng He. Efficacy and safety of transarterial chemoembolization combined with lenvatinib and camrelizumab in patients with BCLC-defined stage C hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1244341
|
| 24 |
Liang Liu, Zheng‐Gang Ren, Yuan Shen, Xiao‐Dong Zhu, Wei Zhang, Wei Xiong, Yi Qin, Zhao‐You Tang. Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model: Relevance of epithelial–mesenchymal transition. Cancer Science 2010; 101(1): 120 doi: 10.1111/j.1349-7006.2009.01363.x
|
| 25 |
Yang Guo, Yue Zhang, Ning Jin, Rachel Klein, Jodi Nicolai, Robert J. Lewandowski, Robert K. Ryu, Reed A. Omary, Andrew C. Larson. Electroporation-Mediated Transcatheter Arterial Chemoembolization in the Rabbit VX2 Liver Tumor Model. Investigative Radiology 2012; 47(2): 116 doi: 10.1097/RLI.0b013e31822e57cc
|
| 26 |
H. Cha, H. I. Yoon, I. J. Lee, W. S. Koom, K.-H. Han, J. Seong. Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma. Journal of Radiation Research 2013; 54(6): 1069 doi: 10.1093/jrr/rrt034
|
| 27 |
Chuang Jiang, Gong Cheng, Mingheng Liao, Jiwei Huang. Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02188-4
|
| 28 |
Wen W. Ma, Wells A. Messersmith. Interventional Oncology. 2008; : 222 doi: 10.1017/CBO9780511722226.020
|
| 29 |
Jean-François Dufour, Hanno Hoppe, Markus H. Heim, Beat Helbling, Olivier Maurhofer, Zsolt Szucs-Farkas, Ralph Kickuth, Markus Borner, Daniel Candinas, Bettina Saar. Continuous Administration of Sorafenib in Combination with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Results of a Phase I Study. The Oncologist 2010; 15(11): 1198 doi: 10.1634/theoncologist.2010-0180
|
| 30 |
Steven Lahti, Johannes M. Ludwig, Minzhi Xing, Lingyi Sun, Dexing Zeng, Hyun S. Kim, Yi-Hsien Hsieh. In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma—A pilot study. PLOS ONE 2017; 12(4): e0174539 doi: 10.1371/journal.pone.0174539
|
| 31 |
Richard H. Pin, Maura Reinblatt, William J. Bowers, Howard J. Federoff, Yuman Fong. Herpes simplex virus amplicon delivery of a hypoxia-inducible angiogenic inhibitor blocks capillary formation in hepatocellular carcinoma. Journal of Gastrointestinal Surgery 2004; 8(7): 812 doi: 10.1016/j.gassur.2004.08.007
|
| 32 |
Li Li, Jia-Ling Huang, Qi-Cai Liu, Pei-Hong Wu, Ran-Yi Liu, Yi-Xin Zeng, Wen-Lin Huang. Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery. World Journal of Gastroenterology 2004; 10(13): 1867-1871 doi: 10.3748/wjg.v10.i13.1867
|
| 33 |
Adriana Sergio, Chiara Cristofori, Romilda Cardin, Giorgio Pivetta, Roberto Ragazzi, Anna Baldan, Lisa Girardi, Umberto Cillo, Patrizia Burra, Anna Giacomin, Fabio Farinati. Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness. The American Journal of Gastroenterology 2008; 103(4): 914 doi: 10.1111/j.1572-0241.2007.01712.x
|
| 34 |
Sanjay Gupta, Satoshi Kobayashi, Sith Phongkitkarun, Lyle D. Broemeling, Zuxing Kan. Effect of Transcatheter Hepatic Arterial Embolization on Angiogenesis in an Animal Model. Investigative Radiology 2006; 41(6): 516 doi: 10.1097/01.rli.0000209663.00629.8a
|
| 35 |
Jean-François Dufour. Targeted Therapies for Hepatocellular Carcinoma. 2011; : 74 doi: 10.2217/ebo.11.287
|
| 36 |
Jun-Ning Liu, Ji-Jiang Li, Shu Yan, Guang-Nian Zhang, Peng-Sheng Yi. Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1074793
|
| 37 |
A. Lam, D. Fernando, C.C. Sirlin, M. Nayyar, S.C. Goodwin, D.K. Imagawa, C. Lall. Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisation. Clinical Radiology 2017; 72(11): 994.e9 doi: 10.1016/j.crad.2017.07.003
|
| 38 |
Mary A. Maluccio, Anne M. Covey, Leah Ben Porat, Joanna Schubert, Lynn A. Brody, Constantinos T. Sofocleous, George I. Getrajdman, William Jarnagin, Ronald DeMatteo, Leslie H. Blumgart, Yuman Fong, Karen T. Brown. Transcatheter Arterial Embolization with Only Particles for the Treatment of Unresectable Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2008; 19(6): 862 doi: 10.1016/j.jvir.2008.02.013
|
| 39 |
Zizhuo Wang, Qing Li, Bin Liang. Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma. Pharmaceuticals 2024; 17(8): 1057 doi: 10.3390/ph17081057
|
| 40 |
Jean-Marc Idée, Boris Guiu. Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: A review. Critical Reviews in Oncology/Hematology 2013; 88(3): 530 doi: 10.1016/j.critrevonc.2013.07.003
|
| 41 |
Angelo Della Corte, Margherita Rimini, Stephanie Steidler, Diego Palumbo, Francesca Ratti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini, Francesco De Cobelli. Combined Loco-Regional and Systemic Treatment Strategies for Hepatocellular Carcinoma: From Basics to New Developments. CardioVascular and Interventional Radiology 2023; 46(2): 175 doi: 10.1007/s00270-022-03327-4
|
| 42 |
Zhen Fan Yang, Ronnie T.P. Poon, Yuqing Liu, Chi Keung Lau, David W. Ho, Ka Ho Tam, Chi Tat Lam, Sheung Tat Fan. High doses of tyrosine kinase inhibitor PTK787 enhance the efficacy of ischemic hypoxia for the treatment of hepatocellular carcinoma: dual effects on cancer cell and angiogenesis. Molecular Cancer Therapeutics 2006; 5(9): 2261 doi: 10.1158/1535-7163.MCT-06-0149
|
| 43 |
Bendaxin Cao, Ke Tian, Hejun Zhou, Chenjie Li, Deliang Liu, Yuyong Tan. Hepatic Arterioportal Fistulas: A Retrospective Analysis of 97 Cases. Journal of Clinical and Translational Hepatology 2022; 10(4): 620 doi: 10.14218/JCTH.2021.00100
|